Compare Merck & Co., Inc. (MRK) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Merck & Co., Inc. trades at $148 (market cap $363.98B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $211.37 (market cap $39.48B). The key difference: Merck & Co., Inc. is far larger — about 9.2× TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock's market cap, and Merck & Co., Inc. pays a 2.3% dividend while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock pays none. Which is the better fit depends on your goals.
| MRK | TTWO | |
|---|---|---|
Market Cap | $363.98B | $39.48B |
Sector | Health | Media |
52-Week High | $156.43 | $262.29 |
52-Week Low | $77.60 | $189.69 |
Enterprise Value | $410.75B | $40.60B |
Dividend Yield | 2.3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MRK trades at $148.49, down 1.23% on the day, with a bullish technical signal from moving averages and support near $147. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.22. Revenue reached $65.01B in 2025, and the acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline.
Outlook remains positive with a consensus price target of $157, offering ~6% upside. Risks include high P/E of 118.77 and competitive pressures in pharma. Institutional buying and a 67.57% buy rating from analysts support a constructive view, though net income margin of 4.77% warrants monitoring.
Take-Two Interactive (TTWO) trades at $213.29, down 0.65% on the day, amid bearish technical signals but strong analyst optimism driven by the upcoming Grand Theft Auto VI launch. The stock shows negative profitability with a net income margin of -4.79% and elevated valuation ratios, yet revenue growth to $5.63 billion in 2025 and recent earnings beats highlight operational resilience. Cash flow trends are volatile, with 2025 net cash flow positive at $457 million due to financing activities, while debt-to-asset ratio rose to 39.87%.
The outlook hinges on GTA VI's success, with a consensus price target of $302.60 implying significant upside. Risks include execution missteps, competitive pressures, and high debt, but institutional buying and no sell ratings reflect confidence in the long-term franchise value. Near-term volatility is expected around product launches and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →
